tislelizumab,Sorafenib
BeiGene,bayer
['tislelizumab', 'beigene', '$bgne']
$bgne beigene announces data presentations at esmo 2022 including late-breaking oral presentation for tislelizumab in first-line unresectable hepatocellular cancer #cancer stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.